Tracking resistant bacteria in cirrhosis patients
Part of Digestive system clinical trials.
This study monitors patients with worsening cirrhosis for certain hard-to-treat bacteria in the gut. It aims to understand how these bacteria spread and how to prevent infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the hospital.
- You have cirrhosis that has suddenly gotten worse.
- You have not had liver surgery or an organ transplant.
- You are not taking part in another clinical trial now or in the past 3 months.
- You will be in the hospital for at least 2 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a mixture of helpful bacteria can improve gut health in people hospitalized with serious liver problems. It aims to see if restoring these bacteria can help with recovery.
This trial uses a DNA test to better detect infections in people with advanced liver disease who are hospitalized. It may help doctors find the right treatment faster.
This study looks at bacterial infections in people with cirrhosis to understand which antibiotics still work. The goal is to improve treatment for future patients with liver disease.
This study looks at the bacteria naturally living in your gut (the microbiome) to better understand liver cirrhosis. It does not test a new drug or treatment, only collects information and samples.
This study compares standard antibiotic treatment versus antibiotic choices guided by local infection tracking (epidemiological surveillance) in people with cirrhosis who have an acute worsening and likely a bacterial infection. It may help doctors choose antibiotics more accurately and safely in this high-risk situation.
This study looks at infections in people with cirrhosis caused by hepatitis B or C. It aims to find which germs cause these infections, so doctors can choose better treatments.
Hear when a new Cirrhosis, Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.